web.icadmed.comArtificial Intelligence for Cancer Detection | iCAD

New Webinar | Revolutionizing Cancer Care: ​The Role of AI in Breast Imaging. | May 22, 2024 9:00 am PT • 12:00 pm ET | Save Your Seat iCADContact Us Blog Login Search For Providers Show submenu ProFound Breast Health Suite Show submenu Detection Density Assessment Risk Evaluation Heart Health Success Stories ResearchPublications ServiceSupport For Partners For Patients Show submenu Discover AI-powered Mammograms Resources for PatientsShow submenu Company Overview History Science Team Blog NewsEvents Webinars Careers Compliance Request Demo Creating a world where Cancer Can’t Hide. Cancer wins when it hides. Remaining undetected, cancer poses one of the greatest threats to life. When cancer wins, we all lose. But what if cancer couldn’t hide? What if there was a way to expose where it may be hiding and when it’s going to make its move? Learn How iCAD finds cancer Why we exist. Previous Next 1 in 8 women will get breast cancer in her lifetime. 20 – 40 % of cancers are missed in mammogram screenings. 14 seconds Every 14 seconds, a woman is diagnosed with breast cancer world-wide. 63 % Assessing cancer risk with traditional models is only 63% accurate. 33 % 33% of women miss their screening mammogram in a two-year span. 50 % Up to 50% of breast cancers are missed in women with dense breast tissue. 89 % 89% of women diagnosed with breast cancer have no family history of the disease Breast cancer has finally met its match. Know where cancer may be hiding and when it might make its move. For Patients When breast cancer is detected early, the 5-year relative survival rate is 99%. 5 Find cancers at the earliest possible stage. Learn How For Providers Find more invasive cancers, and the interval cancers you fear the most, while cutting your reading time in half by adding ProFound to your workflow. 4 Learn How Our Platform ProFound Breast Health Suite Backed by science, clinical evidence, and proven patient outcomes; our suite of solutions – Detection, Density, and Risk — shine a spotlight on cancer, exposing its hiding place. These clinically proven AI-powered solutions provide certainty and peace of mind, improving patient outcomes and saving more lives. Request Demo Detection ProFound Detection A screening revolution has arrived. The difference is ProFound. Find cancers earlier, with greater accuracy and efficiency. With up to 2x enhanced clinical performance compared to other AI platforms, 3 ProFound Detection offers unrivaled accuracy and workflow advantages. 4 Learn How Density Density Assessment Objective, reliable, consistent density scoring. Breast density can elevate breast cancer risk up to 4x, 6 therefore, density scores impact and inform personalized treatment plans. Simplify and standardize assessments of breast density, with results clinicians rely on and patients understand. Learn How Risk ProFound Risk Know your risk. Protect your future. The world’s first image-based risk model is 2.4x more accurate than traditional models. 1,2 Identify women at high risk of developing cancer before or at their next screening to help find interval cancers, earlier. Learn How Heart Health Heart Health (Coming Soon) Evaluate your heart health. Breast cancer and heart disease are the top two leading causes of death among women. One mammogram can soon assess breast arterial calcifications, alerting you to heart concerns earlier. Learn How About iCAD Remaining unseen and insidious, hidden cancer poses one of the greatest threats to life. When cancer wins, we all lose. But what if cancer couldn’t hide? What if there was a way to expose where it may be hiding and when it’s going to make its move? Play Video THE PROOF Precise, powerful , proven 25 Years of Experience 50 Available in 50 Countries 45 Patents Granted 51 Clinical Studies 100 Clinical Sites sourcing Images for Algorithm Diversity 6 Million Images Trained Algorithm 4 th Generation AI Algorithm smashicons_online_streaming_approved-63-icon-outline 1 FDA Cleared. CE Marked. Health Canada Licensed. In the last five years alone, iCAD estimates reading more than 40 million mammograms worldwide, of which nearly 30% are tomosynthesis. learn more about icad Expert Voices Joining forces against a common enemy. In the fight against cancer, we’re stronger together. Learn why our customers believe that our solutions are the secret weapon for cancer detection and treatment. View All Testimonials Previous Next As soon as we implemented ProFound AI, we started using it on all of our DBT breast cancer screenings. It greatly improved our workflow and enabled us to get back to rapid reads and offered the opportunity to provide results for patients in real-time. Lisa Sheppard MD, PINK Breast Center After comparing all available options, we felt that iCAD’s technology was simply the best. We needed an AI solution that would allow us to read mammograms from either the Hologic workstation or from the Intelerad® PACS. ProFound AI, which supports multiple output formats, was able to provide that flexibility. Matt Dewey Chief Information Officer, Wake Radiology We decided to adopt ProFound AI because we felt it was the best product available to provide valid CAD markers on DBT. We also found iCAD’s other breast AI solutions enticing, such as PowerLook Density Assessment and ProFound AI Risk, as technologies we would like to assess. Arnold B. Honick MD, Diagnostic Radiology Specialist at RCI Our Partners ProFound Partnerships Proud to work with leading industry, research, technology, and advocacy partners. Previous Next Platform Partners Platform Partners Research Partners Platform Partners Platform Partners Integration Partners Platform Partners Integration Partners Platform Partners Integration Partners Integration Partners Integration Partners Integration Partners Integration Partners Integration Partners Integration Partners Integration Partners Integration Partners Platform Partners Platform Partners Platform Partners Platform Partners Platform Partners Integration Partners Research Partners Research Partners Research Partners Research Partners Research Partners See All Partners The Latest In The Spotlight Previous Next Blog Know Before: Breast Cancer Risk Factors at Every Age May 6, 2024 As we recognize Women’s Health Month, we want to celebrate the moms, grandmothers, sisters, daughters, aunts, nieces, and cousins who are making a profound impact in their communities, paving the way for a healthier future, and inspiring hope for generations to come. Breast cancer is a significant health concern affecting… Read More Press Release iCAD to Report First Quarter 2024 Financial Results on May 15, 2024 May 2, 2024 UPDATE: Call Time is 8:30 AM Eastern Time NASHUA, N.H., May 2, 2024 — iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today it will release financial results for the first quarter ended March 31, 2024, pre-market and host a conference call at… Read More Webinar Revolutionizing Cancer Care: The Role of AI in Breast Imaging​ Webinar May 22, 2024 Hear from Dr. Nikki Gidwaney, Breast Radiologist, Stony Brook University Hospital, as she discusses how breast imaging centers are staying at the forefront with best-in-class AI solutions. She will highlight her personal journey with Breast AI solutions and the power of iCAD’s newest algorithm in helping imaging centers meet key… Read More Event SIFEM 2024 Booth 11 Nantes France Jun 13 – Jun 15, 2024 Booth 11 | Nantes, France | June 13-15, 2024 Read More Blog Improve Workstation Readability with ProFound AI Detection v3 Service Pack April 11, 2024 ProFound AI Detection delivers clarity, confidence, and peace of mind. ProFound is clinically proven to improve breast cancer detection and radiologist performance. FDA Cleared. CE Marked. Health Canada Licensed. Read More Press Release iCAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation...